Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | April 25, 2014 | April 29, 2014 |
| Amesite Inc.NONE · Entity 149985 | Director | March 31, 2020 | April 06, 2020 |
| Amesite Inc.AMST · Entity 8151 | Director | September 30, 2026 | October 03, 2026 |
| Elicio Therapeutics, Inc.ANGN · Entity 299 | Director | June 09, 2022 | June 13, 2022 |
| Esperion Therapeutics, Inc.ESPR · Entity 30796 | Director | April 17, 2017 | April 19, 2017 |
| GALECTIN THERAPEUTICS INCGALT · Entity 5577 | Director | January 16, 2026 | January 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date April 25, 2014 · Filed April 29, 2014
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 180,547 |
Reported balance
After 2014-04-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2014-04-25 · Grant · Acquired 1,795 · Balance 180,547 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2: These shares include 232 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
F2: These shares include 232 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Amesite Inc.
Report date March 31, 2020 · Filed April 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2030-03-31 | Direct | 50,000 |
Reported balance
After 2020-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-03-31 · Grant · Acquired 50,000 · Balance 50,000 F1: 50% of the options shall vest on March 31, 2021 and the remaining 50% of the options shall vest and become exercisable in twelve (12) successive equal monthly installments thereafter. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2030-03-31 | Direct | 10,000 |
Reported balance
After 2020-03-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-31 · Grant · Acquired 10,000 · Balance 10,000 F2: 50% of the options shall vest on March 31, 2021 and the remaining 50% of the options shall vest and become exercisable in twelve (12) successive equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: 50% of the options shall vest on March 31, 2021 and the remaining 50% of the options shall vest and become exercisable in twelve (12) successive equal monthly installments thereafter.
F2: 50% of the options shall vest on March 31, 2021 and the remaining 50% of the options shall vest and become exercisable in twelve (12) successive equal monthly installments thereafter.
Amesite Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectBy Gilbert S. Omenn Revocable Trust | 95,927 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 12,121 · Balance 95,927 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share.
F2: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control.
Elicio Therapeutics, Inc.
Report date June 09, 2022 · Filed June 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.73 · Expires 2032-06-09 | Direct | 15,000 |
Reported balance
After 2022-06-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-09 · Grant · Acquired 15,000 · Balance 15,000 F1: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.
Esperion Therapeutics, Inc.
Report date April 17, 2017 · Filed April 19, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.96 · Expires 2027-04-17 | Direct | 14,000 |
Reported balance
After 2017-04-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-04-17 · Grant · Acquired 14,000 · Balance 14,000 F1: The options vest in full on the earlier of (i) April 17, 2018 and (ii) the Issuer's next annual meeting of stockholders following April 17, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest in full on the earlier of (i) April 17, 2018 and (ii) the Issuer's next annual meeting of stockholders following April 17, 2017.
GALECTIN THERAPEUTICS INC
Report date January 16, 2026 · Filed January 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-01-16 | Direct | 60,000 |
Reported balance
After 2026-01-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-16 · Grant · Acquired 60,000 · Balance 60,000 F1: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. F2: The options vest 100% on December 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
F2: The options vest 100% on December 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:05 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 12,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-106364 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 95,927 Underlying: Common Stock · 12,121 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:30 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 9,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-074307 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 83,806 Underlying: Common Stock · 9,023 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 22:52 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 6,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-038719 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 74,783 Underlying: Common Stock · 6,522 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 07, 2026 Filed Mar 11, 2026 01:43 UTC | Amesite Inc. AMST · Entity 8151 | Exercise / conversionRestricted Stock Units · Derivative | 41,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-025891 · ownership.xml · derivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 0 Underlying: Common Stock · 41,322 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F1 · derivative.exercise_date: The reported restricted stock units were granted on March 7, 2025 and vested on March 7, 2026. F1 · derivative.expiration_date: The reported restricted stock units were granted on March 7, 2025 and vested on March 7, 2026. Read SEC document |
| March 07, 2026 Filed Mar 11, 2026 01:43 UTC | Amesite Inc. AMST · Entity 8151 | Exercise / conversionCommon Stock | 41,322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-26-025891 · ownership.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 143,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported restricted stock units were granted on March 7, 2025 and vested on March 7, 2026. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:17 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 49,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-014413 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 49,751 Underlying: Common Stock · 49,751 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The RSUs fully vest on the first anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs fully vest on the first anniversary of the date of grant. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:46 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001133416-26-000026 · form4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2036-01-16 F1 · security: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: The options vest 100% on December 31, 2026. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:10 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 6,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-001119 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 68,261 Underlying: Common Stock · 6,349 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:30 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 3,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-095452 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 61,912 Underlying: Common Stock · 3,934 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 21:23 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-061107 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 57,978 Underlying: Common Stock · 4,461 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:59 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-028248 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 53,517 Underlying: Common Stock · 4,959 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:08 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 41,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-022810 · ownership.xml · derivative · entry 4 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 41,322 Underlying: Common Stock · 41,322 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F4 · derivative.exercise_date: The RSUs fully vest on the first anniversary of the date of grant. F4 · derivative.expiration_date: The RSUs fully vest on the first anniversary of the date of grant. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:08 UTC | Amesite Inc. AMST · Entity 8151 | GrantCommon Stock | 41,322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-022810 · ownership.xml · nonDerivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 102,377 F2 · price: On March 7, 2025, the reporting person was granted 41,322 shares of common stock as compensation for services rendered as a member of the board of directors of the issuer. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:06 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001133416-25-000016 · form4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2035-01-23 F1 · security: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: The options vest 100% on December 31, 2025. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:01 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001133416-25-000002 · form4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2035-01-23 F1 · security: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: The options vest 100% on December 31, 2025. Read SEC document |
| January 16, 2025 Filed Jan 16, 2025 23:21 UTC | Amesite Inc. AMST · Entity 8151 | Exercise / conversionRestricted Stock Units · Derivative | 36,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-004305 · ownership.xml · derivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 0 Underlying: Common Stock · 36,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: On January 16, 2024, the reporting person was granted 36,630 restricted stock units vesting on the first anniversary date of the grant. F2 · derivative.expiration_date: On January 16, 2024, the reporting person was granted 36,630 restricted stock units vesting on the first anniversary date of the grant. Read SEC document |
| January 16, 2025 Filed Jan 16, 2025 23:21 UTC | Amesite Inc. AMST · Entity 8151 | Exercise / conversionCommon Stock | 36,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-004305 · ownership.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 46,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 22:50 UTC | Amesite Inc. AMST · Entity 8151 | PurchaseCommon Stock | 3,333 | $3.00 | $9,999.00 |
DisclosureSEC source: 0001213900-25-002160 · ownership.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 9,805 F1 · price: The shares were purchased in a confidentially marketed public offering pursuant to an underwriting agreement. For more information relating to the offering pursuant to which the reported shares were purchased, please refer to the final prospectus filed by Amesite Inc. with the SEC on January 7, 2025. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:16 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 2,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-000779 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 48,558 Underlying: Common Stock · 2,526 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 23:13 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-084769 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 46,032 Underlying: Common Stock · 4,898 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:49 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-058656 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 41,134 Underlying: Common Stock · 4,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 23:05 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 5,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-028991 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 37,134 Underlying: Common Stock · 5,381 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| January 24, 2024 Filed Feb 7, 2024 21:50 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001133416-24-000020 · form4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-01-24 F1 · security: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: The options vest 100% on December 31, 2024. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:39 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 36,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-004628 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 36,630 Underlying: Common Stock · 36,630 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The RSUs vest over one year, with 100% vesting on the first anniversary date of the grant. F2 · derivative.expiration_date: The RSUs vest over one year, with 100% vesting on the first anniversary date of the grant. Read SEC document |
| December 29, 2023 Filed Jan 4, 2024 00:16 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-000919 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 31,753 Underlying: Common Stock · 5,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:05 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001013762-23-001105 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 26,420 Underlying: Common Stock · 4,706 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:43 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 3,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-054895 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 21,714 Underlying: Common Stock · 3,324 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 01:54 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 4,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-027325 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 18,390 Underlying: Common Stock · 4,598 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F3 · balance_after: On February 21, 2023, a 1-for-12 reverse stock split of the common stock of AMST was effected, resulting in the reporting person's ownership of one-twelfth (1/12) of the number of RSUs owned prior to such reverse stock split. Read SEC document |
| March 31, 2023 Filed Mar 11, 2025 21:08 UTC | Amesite Inc. AMST · Entity 8151 | Exercise / conversionRestricted Stock Units · Derivative | 14,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-022810 · ownership.xml · derivative · entry 3 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 0 Underlying: Common Stock · 14,620 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F1 · derivative.exercise_date: The reported restricted stock units were granted on March 31, 2022 and vested on March 31, 2023. F1 · derivative.expiration_date: The reported restricted stock units were granted on March 31, 2022 and vested on March 31, 2023. Read SEC document |
| March 31, 2023 Filed Mar 11, 2025 21:08 UTC | Amesite Inc. AMST · Entity 8151 | Exercise / conversionCommon Stock | 14,620 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-022810 · ownership.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 61,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported restricted stock units were granted on March 31, 2022 and vested on March 31, 2023. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 21:45 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001133416-23-000024 · form4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-01-26 F1 · security: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: The options vest 100% on December 31, 2023. Read SEC document |
| December 30, 2022 Filed Jan 5, 2023 11:20 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 68,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-000979 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 165,504 Underlying: Common Stock · 68,571 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:10 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 49,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-061257 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 96,933 Underlying: Common Stock · 49,793 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:38 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 26,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-037353 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 47,140 Underlying: Common Stock · 26,087 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 21:26 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | GrantCommon Stock · Derivative | 15,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001601485-22-000050 · wf-form4_165515555115849.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:50 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 84,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-017973 · ownership.xml · derivative · entry 3 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 84,211 Underlying: Common Stock · 84,211 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F4 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F4 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:50 UTC | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 175,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-017973 · ownership.xml · derivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 175,439 Underlying: Common Stock · 175,439 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F3 · derivative.exercise_date: The RSUs vest over one year, with 100% vesting on the first anniversary date of the grant. F3 · derivative.expiration_date: The RSUs vest over one year, with 100% vesting on the first anniversary date of the grant. Read SEC document |
| March 31, 2022 Filed Jul 5, 2022 22:31 UTC Amendment | Amesite Inc. AMST · Entity 8151 | GrantRestricted Stock Units · Derivative | 21,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-037342 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 21,053 Underlying: Common Stock · 21,053 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. F2 · derivative.expiration_date: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. Read SEC document |
| January 24, 2022 Filed Jan 25, 2022 21:33 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001133416-22-000029 · form4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-01-24 F1 · security: The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: The options vest 100% on December 31, 2022. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 21:05 UTC | Amesite Inc. AMST · Entity 8151 | PurchaseCommon Stock | 8,000 | $1.17 | $9,353.60 |
DisclosureSEC source: 0001213900-21-065437 · ownership.xml · nonDerivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 77,666 Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 21:05 UTC | Amesite Inc. AMST · Entity 8151 | PurchaseCommon Stock | 8,000 | $1.18 | $9,471.20 |
DisclosureSEC source: 0001213900-21-065437 · ownership.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 69,666 Read SEC document |
| September 28, 2021 Filed Apr 4, 2022 23:50 UTC | Amesite Inc. AMST · Entity 8151 | GrantStock option (right to buy) · Derivative | 9,184 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001213900-22-017973 · ownership.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert S. Omenn Revocable Trust Disclosed balance after: 9,184 Underlying: Common Stock · 9,184 shares Expires 2031-09-27 F1 · derivative.exercise_date: The option fully vests on the one-year anniversary of the date of grant. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 20:35 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock option (right to buy) · Derivative | 70,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0000899243-21-013812 · doc4.xml · derivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-03-25 F1 · security: The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan. F3 · derivative.exercise_date: Such options vest when (i) the Company has received the interim results of its NAVIGATE clinical trial and (ii) makes a public announcement that it has received the interim results. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 20:35 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0000899243-21-013812 · doc4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-03-25 F1 · security: The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: Such options vest 100% on March 31, 2022. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:07 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0001567619-21-005969 · doc1.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-03-07 F1 · derivative.exercise_date: To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 00:23 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $16.00 | $171,046.24 |
DisclosureSEC source: 0001567619-21-003191 · doc1.xml · derivative · entry 6 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock. F5 · derivative.expiration_date: The convertible promissory note ("Convertible Note") had a maturity date of August 14, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share. F1 · ownership.nature: Gilbert S. Omenn Revocable Trust. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 00:23 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $16.00 | $270,630.14 |
DisclosureSEC source: 0001567619-21-003191 · doc1.xml · derivative · entry 5 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock. F4 · derivative.expiration_date: The convertible promissory note ("Convertible Note") had a maturity date of June 1, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share. F1 · ownership.nature: Gilbert S. Omenn Revocable Trust. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 00:23 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $16.00 | $271,698.64 |
DisclosureSEC source: 0001567619-21-003191 · doc1.xml · derivative · entry 4 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock. F3 · derivative.expiration_date: The convertible promissory note ("Convertible Note") had a maturity date of May 20, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share. F1 · ownership.nature: Gilbert S. Omenn Revocable Trust. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 00:23 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionCommon Stock | 14,783 | $11.57 | $171,039.31 |
DisclosureSEC source: 0001567619-21-003191 · doc1.xml · nonDerivative · entry 3 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 80,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Gilbert S. Omenn Revocable Trust. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 00:23 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionCommon Stock | 23,391 | $11.57 | $270,633.87 |
DisclosureSEC source: 0001567619-21-003191 · doc1.xml · nonDerivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 65,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Gilbert S. Omenn Revocable Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.